Warby Parker Inc. (WRBY) stock
WRBYNYSEOphthalmic GoodsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/30302% above fair value
$25.92−0.31 (-1.18%)
Close on Nov 17, 2026Market cap $3.20BP/E 370.3Yield –
Warby Parker ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Warby Parker's ebitda for the twelve months ending Jun 30, 2026 was $55.02M, up 79.1% year over year. For fiscal 2025 it was $44.94M, up 185.3% from the year before. The highest annual figure on record is $44.94M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.94M | +185.3% |
| FY2024 | Dec 31, 2024 | $15.75M | – |
| FY2023 | Dec 31, 2023 | -$33.44M | – |
| FY2022 | Dec 31, 2022 | -$79.34M | – |
| FY2021 | Dec 31, 2021 | -$122.11M | – |
| FY2020 | Dec 31, 2020 | -$37.87M | -394.6% |
| FY2019 | Dec 31, 2019 | $12.85M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $17.24M | +116.5% |
| Q1 FY2026 | Mar 31, 2026 | $15.44M | +5.5% |
| Q4 FY2025 | Dec 31, 2025 | $6.25M | +114.3% |
| Q3 FY2025 | Sep 30, 2025 | $16.10M | +208.7% |
| Q2 FY2025 | Jun 30, 2025 | $7.96M | +267.7% |
| Q1 FY2025 | Mar 31, 2025 | $14.63M | +168.2% |
| Q4 FY2024 | Dec 31, 2024 | $2.92M | – |
| Q3 FY2024 | Sep 30, 2024 | $5.22M | – |
| Q2 FY2024 | Jun 30, 2024 | $2.17M | – |
| Q1 FY2024 | Mar 31, 2024 | $5.46M | – |
| Q4 FY2023 | Dec 31, 2023 | -$11.20M | – |
| Q3 FY2023 | Sep 30, 2023 | -$10.01M | – |
| Q2 FY2023 | Jun 30, 2023 | -$8.95M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.29M | – |
| Q4 FY2022 | Dec 31, 2022 | -$12.79M | – |
| Q3 FY2022 | Sep 30, 2022 | -$15.33M | – |
| Q2 FY2022 | Jun 30, 2022 | -$24.20M | – |
| Q1 FY2022 | Mar 31, 2022 | -$26.83M | -447.3% |
| Q4 FY2021 | Dec 31, 2021 | -$39.53M | – |
| Q3 FY2021 | Sep 30, 2021 | -$86.62M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.69M | – |
| Q1 FY2021 | Mar 31, 2021 | $7.73M | – |
| Q4 FY2020 | Dec 31, 2020 | -$648.00K | – |
See a number that looks wrong?